Heap of medical pills in white, blue and other colors. Pills in plastic package. With a number of new medicines expected to launch that will have a significant impact for patients across new disease areas, 2023 will be a milestone year for biosimilars.

Reducing the high cost of prescriptions that both employers and employees pay at the pharmacy is no easy task. Demographic changes and the increase of available pharmaceutical solutions is driving up prices. However, the use of generic and so-called biosimilar drugs can help. While generics use identical ingredients to their FDA-approved brand-name cousins, biosimilars, while not using identical ingredients, have been shown to work the same in the body.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.